FMO5 and Hepatic fibrosis: These results enhanced the notion that NADPH oxidase might be a crucial mediator of fibrogenic actions of leptin 26, implying that NADPH oxidase pathway could be considered as a possible target for inhibiting leptin‐induced liver fibrosis.